PRWeb.com Press Release Feed - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/131502.xml PRWeb.com Press Release Feed - Press Releases en xml@emediawire.com xml@emediawire.com 30 Lowest Price for Merck's New Diabetes Drug Januvia Found at MyFloridaPharmacy.com http://www.prweb.com/releases/2006/11/prweb483378.htm A survey of major pharmacies by Senior Health Report found the lowest U.S. price for Merck's new diabetes drug Januvia at MyFloridaPharmacy.com. The survey found prices of a normal month's supply of 30 pills of the 100 mg dosage of Januvia (sitagliptin) were some $20 higher at CVS, Target and Wal-Mart than at MyFloridaPharmacy.com. The survey found prices of other diabetes drugs such as Actos, Avandia and Byetta were also lower at MyFloridaPharmacy.com The licensed Florida pharmacy, which is top rated by PharmacyChecker.com, said it can ship Januvia, Actos, Avandia and Byetta to most of the United States with no shipping charge. (PRWeb Nov 27, 2006)

Read the full story at http://www.prweb.com/releases/2006/11/prweb483378.htm

]]> Mon, 27 Nov 2006 08:00:00 GMT http://www.prweb.com/releases/2006/11/prweb483378.htm MyFloridaPharmacy.com Beats Wal-Mart & Target; Sells Same Medications for $3.79 http://www.prweb.com/releases/2006/11/prweb470642.htm A Florida pharmacy that has been providing prescription medications to people around the country for the past eight years announced it will beat Wal-Mart and Target's new lower prescription prices by a minimum of 5 percent, and will sell the generic drugs they are offering for $4 to consumers all across the United States for only $3.79. The Florida pharmacy, which is one-upping Wal-Mart and Target by offering amazingly low prescription prices to all of America through its new website called MyFloridaPharmacy.com, said its prices on most other drugs will beat not just the two U.S. giants but often Canadian Internet pharmacies as well. (PRWeb Nov 3, 2006)

Read the full story at http://www.prweb.com/releases/2006/11/prweb470642.htm

]]> Fri, 03 Nov 2006 08:00:00 GMT http://www.prweb.com/releases/2006/11/prweb470642.htm AlliReport.com Provides Latest News About Over-the-Counter Alli, Low-Dose Xenical http://www.prweb.com/releases/2006/01/prweb336305.htm AlliReport.com, an independent news site published by Medical Week News, Inc., provides the latest news about Alli, trade name for low-dose Xenical. Alli, which is half the strength of prescription Xenical (orlistat), is seeking approval to become the first prescription weight-loss drug to be sold over-the-counter. Medical Week News also publishes the highly rated site, AcompliaReport.com, reporting on the new prescription weight-loss drug, Acomplia (rimonabant). (PRWeb Jan 23, 2006)

Read the full story at http://www.prweb.com/releases/2006/01/prweb336305.htm

]]> Mon, 23 Jan 2006 08:00:00 GMT http://www.prweb.com/releases/2006/01/prweb336305.htm Lawsuit Settled -- Sanofi-Aventis Agrees Not to Interfere With News Site AcompliaReport.com http://www.prweb.com/releases/2005/11/prweb308546.htm Eight months after Sanofi-Aventis sought to shutdown www.AcompliaReport.com, leading independent source of news about the new anti-obesity drug Acomplia (rimonabant), the parties reached an agreement under which Sanofi will not interfere with publication of the internet newsletter. The agreement was reached after the Electronic Frontier Foundation sued Sanofi in U.S. District Court in San Francisco. (PRWeb Nov 9, 2005)

Read the full story at http://www.prweb.com/releases/2005/11/prweb308546.htm

]]> Wed, 09 Nov 2005 08:00:00 GMT http://www.prweb.com/releases/2005/11/prweb308546.htm News About Obesity Drug Acomplia (rimonabant) and Diabetes Available From www.AcompliaReport.com http://www.prweb.com/releases/2005/06/prweb249700.htm First results from a one-year trial of Acomplia (rimonabant) in reducing risk factors for obese diabetics can be found in The Acomplia Report (http://www.AcompliaReport.com). (PRWeb Jun 11, 2005)

Read the full story at http://www.prweb.com/releases/2005/06/prweb249700.htm

]]> Sat, 11 Jun 2005 07:00:00 GMT http://www.prweb.com/releases/2005/06/prweb249700.htm Sanofi-Aventis Seeks to Shut Down News Coverage by the Acomplia Report http://www.prweb.com/releases/2005/05/prweb235612.htm The French pharmaceutical giant, Sanofi-Aventis, is attempting to shut down news coverage by the Acomplia Report just as it prepares to seek regulatory approval for its highly touted diet drug Acomplia (rimonabant). The Acomplia Report has for the past year been the most comprehensive independent source of news and information about rimonabant, and Sanofi's action appears designed to shut off independent news coverage at a critical stage of the approval process. (PRWeb May 3, 2005)

Read the full story at http://www.prweb.com/releases/2005/05/prweb235612.htm

]]> Tue, 03 May 2005 07:00:00 GMT http://www.prweb.com/releases/2005/05/prweb235612.htm Acomplia Report to Have New Rimonabant News on March 8th http://www.prweb.com/releases/2005/03/prweb213829.htm Acomplia Report to Cover Latest Rimonabant Trial Results at American College of Cardiology Meeting in Orlando (PRWeb Mar 3, 2005)

Read the full story at http://www.prweb.com/releases/2005/03/prweb213829.htm

]]> Thu, 03 Mar 2005 08:00:00 GMT http://www.prweb.com/releases/2005/03/prweb213829.htm